CUE icon

Cue Biopharma

97 hedge funds and large institutions have $241M invested in Cue Biopharma in 2020 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

2.37% less ownership

Funds ownership: 66.16%63.79% (-2.4%)

17% less capital invested

Capital invested by funds: $291M → $241M (-$49.8M)

87% less call options, than puts

Call options by funds: $359K | Put options by funds: $2.72M

Holders
97
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$359K
Puts
$2.72M
Net Calls
Net Calls Change

Top Buyers

1 +$5.98M
2 +$3.79M
3 +$2.46M
4
Millennium Management
Millennium Management
New York
+$2.28M
5
Goldman Sachs
Goldman Sachs
New York
+$2.2M

Top Sellers

1 -$17.7M
2 -$5.06M
3 -$2.37M
4
Federated Hermes
Federated Hermes
Pennsylvania
-$1.12M
5
BL
Bleichroeder LP
New York
-$938K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$31.4M
2
$27.1M
3
$24M
4
$18.6M
5
$18.1M
6
$17.4M
7
$11.3M
8
$6.81M
9
$6.42M
10
$6.38M
11
$6.05M
12
$5.66M
13
$5.39M
14
$4.54M
15
$4.39M
16
$4.3M
17
$4.07M
18
$4M
19
$2.76M
20
$2.45M
21
$2.31M
22
$1.88M
23
$1.78M
24
$1.75M
25
$1.44M